Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Change in Accured Expenses: 2010-2025

Historic Change in Accured Expenses for Mesa Laboratories (MLAB) over the last 16 years, with Sep 2025 value amounting to -$2.6 million.

  • Mesa Laboratories' Change in Accured Expenses fell 4.16% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year increase of 244.85%. This contributed to the annual value of $9.5 million for FY2025, which is 868.93% up from last year.
  • Mesa Laboratories' Change in Accured Expenses amounted to -$2.6 million in Q3 2025, which was up 56.53% from -$5.9 million recorded in Q2 2025.
  • Mesa Laboratories' Change in Accured Expenses' 5-year high stood at $7.6 million during Q1 2025, with a 5-year trough of -$5.9 million in Q2 2025.
  • For the 3-year period, Mesa Laboratories' Change in Accured Expenses averaged around $147,636, with its median value being -$1.1 million (2024).
  • As far as peak fluctuations go, Mesa Laboratories' Change in Accured Expenses tumbled by 1,158.76% in 2021, and later skyrocketed by 785.70% in 2025.
  • Over the past 5 years, Mesa Laboratories' Change in Accured Expenses (Quarterly) stood at $3.2 million in 2021, then crashed by 79.71% to $648,000 in 2022, then skyrocketed by 149.85% to $1.6 million in 2023, then soared by 254.79% to $5.7 million in 2024, then fell by 4.16% to -$2.6 million in 2025.
  • Its Change in Accured Expenses was -$2.6 million in Q3 2025, compared to -$5.9 million in Q2 2025 and $7.6 million in Q1 2025.